Compare TTRX & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTRX | CURV |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.2M | 159.2M |
| IPO Year | N/A | 2021 |
| Metric | TTRX | CURV |
|---|---|---|
| Price | $7.78 | $2.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $8.00 | $1.59 |
| AVG Volume (30 Days) | 128.5K | ★ 269.7K |
| Earning Date | 05-31-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,000,092,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.57 | $0.94 |
| 52 Week High | $11.69 | $2.66 |
| Indicator | TTRX | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 47.75 | 76.02 |
| Support Level | $4.40 | $1.03 |
| Resistance Level | $11.69 | N/A |
| Average True Range (ATR) | 1.04 | 0.15 |
| MACD | -0.22 | 0.04 |
| Stochastic Oscillator | 4.52 | 88.27 |
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.